Nia Tatsis
2021
In 2021, Nia Tatsis earned a total compensation of $6.6M as EVP & Chief Regulatory and Quality Officer at Vertex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $743,820 |
|---|---|
| Salary | $550,000 |
| Stock Awards | $5,250,173 |
| Other | $40,035 |
| Total | $6,584,028 |
Tatsis received $5.3M in stock awards, accounting for 80% of the total pay in 2021.
Tatsis also received $743.8K in non-equity incentive plan, $550K in salary and $40K in other compensation.
Rankings
In 2021, Nia Tatsis' compensation ranked 1,890th out of 12,415 executives tracked by ExecPay. In other words, Tatsis earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,890 out of 12,415 | 85th |
Division Manufacturing | 709 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 267 out of 2,375 | 89th |
Industry group Drugs | 227 out of 2,096 | 89th |
Industry Pharmaceutical Preparations | 154 out of 1,546 | 90th |
Source: SEC filing on April 7, 2022.
Tatsis' colleagues
We found four more compensation records of executives who worked with Nia Tatsis at Vertex Pharmaceuticals in 2021.